BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17415789)

  • 1. Survival of bone marrow-derived mesenchymal stem cells in a xenotransplantation model.
    Wang Y; Chen X; Armstrong MA; Li G
    J Orthop Res; 2007 Jul; 25(7):926-32. PubMed ID: 17415789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fates and osteogenic differentiation potential of human mesenchymal stem cells in immunocompromised mice.
    Xia Z; Locklin RM; Triffitt JT
    Eur J Cell Biol; 2008 Jun; 87(6):353-64. PubMed ID: 18417247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of EGFP-labeled mesenchymal stem cells and redistribution of allogeneic cells after subcutaneous implantation.
    Duan X; Yang L; Dong S; Xin R; Chen G; Guo L
    Arch Orthop Trauma Surg; 2008 Jul; 128(7):751-9. PubMed ID: 18265994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow mesenchymal stem cells form ectopic woven bone in vivo through endochondral bone formation.
    Chang SC; Tai CL; Chung HY; Lin TM; Jeng LB
    Artif Organs; 2009 Apr; 33(4):301-8. PubMed ID: 19335406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonadherent cell population of human marrow culture is a complementary source of mesenchymal stem cells (MSCs).
    Wan C; He Q; McCaigue M; Marsh D; Li G
    J Orthop Res; 2006 Jan; 24(1):21-8. PubMed ID: 16419965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of osteogenic ability of rat mesenchymal stem cells from bone marrow, periosteum, and adipose tissue.
    Hayashi O; Katsube Y; Hirose M; Ohgushi H; Ito H
    Calcif Tissue Int; 2008 Mar; 82(3):238-47. PubMed ID: 18305886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenic effects despite limited cell survival of bone marrow-derived mesenchymal stem cells under ischemia.
    Hoffmann J; Glassford AJ; Doyle TC; Robbins RC; Schrepfer S; Pelletier MP
    Thorac Cardiovasc Surg; 2010 Apr; 58(3):136-42. PubMed ID: 20379963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of humoral response to allogeneic porcine mesenchymal stem cell with 12 days of tacrolimus.
    Poncelet AJ; Nizet Y; Vercruysse J; Hiel AL; Saliez A; Gianello P
    Transplantation; 2008 Dec; 86(11):1586-95. PubMed ID: 19077894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human umbilical cord mesenchymal stem cells: osteogenesis in vivo as seed cells for bone tissue engineering.
    Diao Y; Ma Q; Cui F; Zhong Y
    J Biomed Mater Res A; 2009 Oct; 91(1):123-31. PubMed ID: 18767055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue transglutaminase is essential for integrin-mediated survival of bone marrow-derived mesenchymal stem cells.
    Song H; Chang W; Lim S; Seo HS; Shim CY; Park S; Yoo KJ; Kim BS; Min BH; Lee H; Jang Y; Chung N; Hwang KC
    Stem Cells; 2007 Jun; 25(6):1431-8. PubMed ID: 17347495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-engineered bone formation with cryopreserved human bone marrow mesenchymal stem cells.
    Liu G; Shu C; Cui L; Liu W; Cao Y
    Cryobiology; 2008 Jun; 56(3):209-15. PubMed ID: 18430412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model.
    Kyriakou C; Rabin N; Pizzey A; Nathwani A; Yong K
    Haematologica; 2008 Oct; 93(10):1457-65. PubMed ID: 18728032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embedding of bone samples in methylmethacrylate: a suitable method for tracking LacZ mesenchymal stem cells in skeletal tissues.
    Hannouche D; Raould A; Nizard RS; Sedel L; Petite H
    J Histochem Cytochem; 2007 Mar; 55(3):255-62. PubMed ID: 17101724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
    Prigozhina TB; Khitrin S; Elkin G; Eizik O; Morecki S; Slavin S
    Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced survival of bone-marrow-derived pluripotent stem cells in an animal model of auditory neuropathy.
    Matsuoka AJ; Kondo T; Miyamoto RT; Hashino E
    Laryngoscope; 2007 Sep; 117(9):1629-35. PubMed ID: 17632425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo.
    Poncelet AJ; Vercruysse J; Saliez A; Gianello P
    Transplantation; 2007 Mar; 83(6):783-90. PubMed ID: 17414713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-culture period of mesenchymal stem cells in osteogenic media influences their in vivo bone forming potential.
    Castano-Izquierdo H; Alvarez-Barreto J; van den Dolder J; Jansen JA; Mikos AG; Sikavitsas VI
    J Biomed Mater Res A; 2007 Jul; 82(1):129-38. PubMed ID: 17269144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vitamin D pretreatment of human mesenchymal stem cells on ectopic bone formation.
    De Kok IJ; Hicok KC; Padilla RJ; Young RG; Cooper LF
    J Oral Implantol; 2006; 32(3):103-9. PubMed ID: 16836173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of mesenchymal tissues-derived stem cells for in vivo chondrogenesis: suitable conditions for cell therapy of cartilage defects in rabbit.
    Koga H; Muneta T; Nagase T; Nimura A; Ju YJ; Mochizuki T; Sekiya I
    Cell Tissue Res; 2008 Aug; 333(2):207-15. PubMed ID: 18560897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis.
    Augello A; Tasso R; Negrini SM; Cancedda R; Pennesi G
    Arthritis Rheum; 2007 Apr; 56(4):1175-86. PubMed ID: 17393437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.